Search filters

List of works by Ly Tu

A critical role for p130Cas in the progression of pulmonary hypertension in humans and rodents

scientific article published on 12 July 2012

A genome-wide association analysis identifies PDE1A|DNAJC10 locus on chromosome 2 associated with idiopathic pulmonary arterial hypertension in a Japanese population

scientific article published on 24 August 2017

Additive Protective Effects of Sacubitril/Valsartan and Bosentan on Vascular Remodeling in Experimental Pulmonary Hypertension

scientific article published on 11 July 2020

Altered TGFβ/SMAD Signaling in Human and Rat Models of Pulmonary Hypertension: An Old Target Needs Attention

scientific article published on 06 January 2021

An endothelial activin A-bone morphogenetic protein receptor type 2 link is overdriven in pulmonary hypertension

scientific article published on 19 March 2021

Angiomatoid fibrous histiocytoma of the pulmonary artery: a multidisciplinary discussion.

scientific article

Chronic inflammation within the vascular wall in pulmonary arterial hypertension: more than a spectator

scientific article published on 01 April 2020

Connexin-43 is a promising target for pulmonary hypertension due to hypoxaemic lung disease

scientific article published on 12 March 2020

Contribution of Impaired Parasympathetic Activity to Right Ventricular Dysfunction and Pulmonary Vascular Remodeling in Pulmonary Arterial Hypertension.

scientific article published on 22 November 2017

Dasatinib increases endothelial permeability leading to pleural effusion

scientific article published on 18 January 2018

Dasatinib induces lung vascular toxicity and predisposes to pulmonary hypertension.

scientific article published on 02 August 2016

Delayed Microvascular Shear Adaptation in Pulmonary Arterial Hypertension. Role of Platelet Endothelial Cell Adhesion Molecule-1 Cleavage.

scientific article published on 13 January 2016

Design, Synthesis, and Biological Activity of New N-(Phenylmethyl)-benzoxazol-2-thiones as Macrophage Migration Inhibitory Factor (MIF) Antagonists: Efficacies in Experimental Pulmonary Hypertension

scientific article published on 10 March 2018

Dichloroacetate treatment partially regresses established pulmonary hypertension in mice with SM22alpha-targeted overexpression of the serotonin transporter.

scientific article published on 13 August 2009

Ectopic upregulation of membrane-bound IL6R drives vascular remodeling in pulmonary arterial hypertension

article by Yuichi Tamura et al published 1 May 2018 in Journal of Clinical Investigation

Emerging molecular targets for anti-proliferative strategies in pulmonary arterial hypertension.

scientific article published on January 2013

Immune dysregulation and endothelial dysfunction in pulmonary arterial hypertension: a complex interplay

scientific article published on March 2014

Leptin and regulatory T-lymphocytes in idiopathic pulmonary arterial hypertension

scientific article published on 23 February 2012

Leptin signalling system as a target for pulmonary arterial hypertension therapy

scientific article published on 05 March 2015

Lineage Tracing Reveals the Dynamic Contribution of Pericytes to the Blood Vessel Remodeling in Pulmonary Hypertension

scientific article published on 23 January 2020

Lower Plasma Melatonin Levels Predict Worse Long-Term Survival in Pulmonary Arterial Hypertension

scientific article published on 25 April 2020

Macrophage Migration Inhibitory Factor (MIF) Inhibition in a Murine Model of Bleomycin-Induced Pulmonary Fibrosis

scientific article published on 18 December 2018

N-acetylcysteine improves established monocrotaline-induced pulmonary hypertension in rats

scientific article

Neutralization of CXCL12 attenuates established pulmonary hypertension in rats

scientific article published on 01 March 2020

New molecular targets of pulmonary vascular remodeling in pulmonary arterial hypertension: importance of endothelial communication

scientific article

New targets for pulmonary arterial hypertension: going beyond the currently targeted three pathways

scientific article published on 02 June 2017

Nintedanib improves cardiac fibrosis but leaves pulmonary vascular remodelling unaltered in experimental pulmonary hypertension

article

Pan-PPAR agonist IVA337 is effective in experimental lung fibrosis and pulmonary hypertension

scientific article published on 11 August 2017

Pathogenesis of pulmonary arterial hypertension: lessons from cancer

scientific article published on December 2013

Prevention of progression of pulmonary hypertension by the Nur77 agonist 6-mercaptopurine: role of BMP signalling

scientific article published on 29 September 2019

Proinflammatory Signature of the Dysfunctional Endothelium in Pulmonary Hypertension. Role of the Macrophage Migration Inhibitory Factor/CD74 Complex

scientific article

Pulmonary hemodynamic responses to inhaled NO in chronic heart failure depend on PDE5 G(-1142)T polymorphism.

scientific article

Purinergic Dysfunction in Pulmonary Arterial Hypertension

scientific article published on 01 September 2020

Regulatory T Cell Dysfunction in Idiopathic, Heritable and Connective Tissue-Associated Pulmonary Arterial Hypertension

scientific article published on 21 January 2016

Renal Denervation Reduces Pulmonary Vascular Remodeling and Right Ventricular Diastolic Stiffness in Experimental Pulmonary Hypertension

scientific article published on February 2017

Response by Guignabert et al to Letter Regarding Article, "Selective BMP-9 Inhibition Partially Protects Against Experimental Pulmonary Hypertension"

scientific article published on 01 April 2019

Right lung ischemia induces contralateral pulmonary vasculopathy in an animal model

article

Role for interleukin-6 in COPD-related pulmonary hypertension

scientific article published on 6 April 2009

Role of Endothelium-derived CC Chemokine Ligand 2 in Idiopathic Pulmonary Arterial Hypertension

scientific article published on 06 September 2007

Role of Nerve Growth Factor in Development and Persistence of Experimental Pulmonary Hypertension

scientific article published in August 2015

Role of Stromelysin 2 (Matrix Metalloproteinase 10) as a Novel Mediator of Vascular Remodeling Underlying Pulmonary Hypertension Associated With Systemic Sclerosis

scientific article published on 13 August 2017

Selective BMP-9 Inhibition Partially Protects Against Experimental Pulmonary Hypertension

scientific article published on 01 March 2019

Switching-Off Adora2b in Vascular Smooth Muscle Cells Halts the Development of Pulmonary Hypertension.

scientific article published in June 2018

T-cell costimulation blockade is effective in experimental digestive and lung tissue fibrosis

scientific article published on 29 August 2018

The BMP Receptor 2 in Pulmonary Arterial Hypertension: When and Where the Animal Model Matches the Patient

scientific article published on 08 June 2020

The Thousand Faces of Leptin in the Lung

scientific article published on 11 August 2020

Therapeutic effect of pirfenidone in the sugen/hypoxia rat model of severe pulmonary hypertension

scientific article published on 27 November 2018

Towards new targets for the treatment of pulmonary arterial hypertension : Importance of cell-cell communications

scientific article

Transgenic Mice Overexpressing the 5-Hydroxytryptamine Transporter Gene in Smooth Muscle Develop Pulmonary Hypertension

scientific article published in 2006

[IL6R is the key therapeutical target in pulmonary arterial hypertension]

scientific article published on 01 October 2018

[New insights in the pathogenesis of pulmonary arterial hypertension]

scientific article published on 19 April 2019